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Hepatic Encephalopathy (HE) is a debilitating neuropsychiatric complication 
associated with acute and chronic liver failure. It is characterized by diverse symptoms with 
variable severity that includes cognitive and motor deficits. The aim of the study is to assess 
metabolic alterations in brain and liver using nuclear magnetic resonance (NMR) 
spectroscopy and subsequent multivariate analyses to characterize metabolic signatures 
associated with HE. HE was developed by bile duct ligation (BDL) that resulted in hepatic 
dysfunctions and cirrhosis as shown by liver function tests. Metabolic profiles from control 
and BDL rats indicated increased levels of lactate, branched chain amino acids (BCAAs), 
glutamate and choline in liver, whereas levels of glucose, phenylalanine and pyridoxine  were 
decreased. In case of brain, the levels of lactate, acetate, succinate, citrate and malate were 
increased, while glucose, creatine, isoleucine, leucine and proline levels were decreased. 
Furthermore, neurotransmitters such as glutamate and GABA were increased, whereas 
choline and myo-inositol were decreased. The alterations in neurotransmitter levels resulted 
in cognitive and motor defects in BDL rats. A significant correlation was found between 
alterations in NAA/choline, choline/creatine and NAA/creatine with behavioural deficits. 
Thus, the data suggests impairment in metabolic pathways such as tricarboxylic acid (TCA) 
cycle, glycolysis and ketogenesis in liver and brain of animals with HE. The study highlights 
that metabolic signatures could be potential marker to monitor HE progression and to assess 
therapeutic interventions. 
Keywords: Behaviour; Brain; Energy metabolism; Hepatic encephalopathy; 
Metabolomics; Liver, Nuclear Magnetic Resonance Spectroscopy.
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Hepatic encephalopathy (HE) is defined as “brain dysfunction resulting from liver 
insufficiency and/or portal systemic shunting that exhibits a wide spectrum of 
psychiatric/neurological abnormalities ranging from subclinical alterations to coma”.1 
Epidemiological reports suggest that majority of patients with cirrhosis develop HE at some 
point of time during the course of the disease. Approximately 30 to 50 % of cirrhotic patients 
develop overt HE and 10 to 50% of them develop minimal HE. Moreover, cirrhotic patients 
suffering from HE have a poor survival rate i.e., 42% after one year and 23% after three years 
of follow-up.2
Hyperammonemia is considered as key contributor in the pathogenesis of HE.3 
Studies have reported the direct effects of ammonia on the cerebral energy metabolism 
affecting glycolysis, tricarboxylic acid (TCA) cycle and electron transport chain.4 Energy 
failure appears to be an important pathogenetic component in HE. Although, disturbance in 
energy metabolism in HE was proposed for the first time in 1955 by Bessman and Bessman 
yet the role of cerebral energy metabolism in the development of chronic HE needs to be 
elucidated for understanding pathogenesis and prognosis. Cerebral energy metabolism has 
also been reported to be impaired in rodent model of HE.5 In brain,  ammonia is metabolised 
to glutamine in astrocytes that impairs energy metabolism at various loci.6,7 Increase in 
glutamine levels that contributes to astrocyte swelling, which results in brain edema.8 Wang 
et al. observed increase in glutamine and branched chain amino acids (BCAAs) in human 
astrocytes treated with ammonium chloride.9  The role of cerebral energy deficits in the 
development of HE has been shown in terms of activation of cerebral AMP-activated protein 
kinase, a major energy sensor in the cell, as a compensatory response to liver failure 
following bile duct ligation, BDL.10 Furthermore, several studies have examined disturbances 
in energy metabolism in HE either in patients11 or in animal models of HE and findings are  
incoherent. Hawkins and Jessy  have reported decrease in cerebral metabolic rate for glucose 
(CMRglc) in portacaval-shunted rats12, while studies by Cruz and Duffy found increase in 
CMRglc13, whereas no change has been reported in hyperammonemic rats.14
Metabolomics analyses all low-molecular weight metabolites and examines metabolic 
changes in various disease conditions and thus provides snapshot of functional endpoint of 
complete biological network and best describes the cellular activity and physiological state.15 It 
has already been successfully applied to highlight disease biomarkers in multiple medical 
fields.16 Moreover, metabolomics approach was also used to study the regional brain metabolic 
patterns in a variety of biological samples such as tissue extracts and bio-fluids.17,18 Nuclear 
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magnetic resonance (NMR) spectroscopy is used to detect a series of cerebral metabolites 
involving energy metabolism, neurotransmitters, membrane metabolism as well as antioxidants 
and osmolytes.19,20 NMR based metabolomics is preferred as routine identification of disease 
specific biomarkers as it requires less time and little sample preparation.21 Moreover, it is 
particularly useful to detect compounds that are less tractable to other analytical methods used 
in metabolomics such as sugars and other highly polar compounds.22 Though, various 
metabolites have been analysed in experimental model of HE and in body fluids of patients 
with HE, however none of the study provides global picture of pathways involved in liver and 
brain in HE.  Therefore, the present study was designed to assess metabolic profiling of liver 
and brain by high-field NMR spectroscopy and subsequent multivariate analyses to 
characterize metabolic perturbations associated with HE along with histological and 
neurobehavioural changes.  
Materials and Methods
Chemicals
Deutrated oxide (2H2O) used for NMR was purchased from Sigma Aldrich (St. Louis, 
MO, USA). Methanol and chloroform were of HPLC grade and purchased from Sisco 
Research Laboratories (SRL) Pvt. Ltd. (Mumbai, India). Absorbable surgical sutures for 
surgery were purchased from Johnson & Johnson Pvt. Ltd. (Mumbai, India). All other 
chemicals used in this study were of analytical grade. 
Animals and Treatment Schedule
Male Wistar rats weighing between 220 and 250 g were obtained from the Central 
Animal House, Panjab University, Chandigarh, India. The animals were allowed to 
acclimatize to the local vivarium for atleast a week prior to the use in study. All the 
experimental protocols were approved by the Institutional Animal Ethics Committee and 
were in accordance with the guidelines for humane use and care of laboratory animals (IAEC 
Approval No: PU/45/99/CPCSEA/IAEC/2018/107). The study was planned for duration of 3 
weeks. The animals were randomly segregated into following two groups with each group 
having six animals:
 Sham control (SC): animals underwent laparotomy without BDL
 BDL: Animals in this group underwent BDL surgery
BDL Surgery
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Laparotomy was performed under general anesthesia using a mixture of ketamine 
(100 mg/kg) and xylazine (10 mg/kg). The sham operation consisted of a laparotomy and bile 
duct identification without ligation. In the BDL rats, bile duct was carefully isolated, doubly 
ligated using suture and then cut between these two ligatures. The abdominal incision was 
closed with absorbable suture (2-0) and the skin incision was closed with normal suture. The 
body temperature of animal was maintained at 37 ± 1oC during the entire surgical procedure. 
The rats were then allowed to recover with free access to chow and water.
Liver function tests
Assays for alkaline phosphatase (ALP), bilirubin and cholesterol were performed in 
serum and plasma using commercially available kits (RECKON, manufactured by reckon 
diagnostic pvt. Ltd.). 
1H NMR based metabolic profiling  
Sample preparation: The tissues (liver, cortex and hippocampus) excised immediately after 
animal sacrifice, were precisely weighed, flash frozen in liquid N2 and stored at -80°C until 
further use. The frozen tissue samples were finely grinded in liquid nitrogen using pre-cooled 
pestle and mortar. The methanol-chloroform-water extraction procedure was used for 
metabolites extraction from the grinded tissue samples as described by  Beckonert et al. 
(2010) with some modifications. Briefly, the grinded tissue sample was mixed with 4 ml of 
chloroform: methanol (1:1 v/v) and vortexed for 1 minute. The mixture was then kept at -
20°C for 30 minutes to precipitate the proteins. Then, 2 ml of ice-cold distilled water was 
added to it and centrifuged at 10,000×g for 15 minutes. The lower organic phase (chloroform) 
and upper aqueous phase (methanol/water) were clearly separated by an insoluble interface. 
The aqueous and organic phases were transferred by pipetting to separate vials. The aqueous 
phase was freeze-dried and reconstituted in 750 μl of deuterium oxide (2H2O), containing 200 
mM phosphate buffer solution (pH=7.4) and 0.5 mM sodium (3-trimethylsilyl)-2,2,3, 3-
tetradeuteriopropionate (TSP), used for internal referene in the NMR specta. The aqueous 
phase was then transferred into a 5-mm NMR tube for NMR measurements.
1H NMR Spectroscopy: The 1H NMR spectra of all tissue samples were acquired on a Biospin 
Avance-III 800 MHz NMR spectrometer operating at 800.21 MHz equipped with crogenic 
probehead and a temperature of 300 °K. For each sample, one-dimensional 1H-NMR spectra 
were recorded using the Carr–Purcell–Meiboom–Gill (CPMG) pulse sequence (cpmgpr1d, 
standard Bruker pulse program) with presaturation of the water peak. All the spectra were 
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processed using Topspin2.1 (Bruker NMR data Processing Software) using standard Fourier 
Transformation (FT) procedure followed by manual phase and baseline-correction. The 
internal standard, TSP was used for chemical shift referencing of its protons at 0 ppm. The 
intensity of the TSP peak was used to determine the relative concentration of each metabolite. 
The spectral analysis and metabolite signal integration was carried out using the ACD NMR 
processor software (Advanced Chemistry Development Inc., Toronto, Canada). The 1H-NMR 
peaks for each metabolite was identified using Human Metabolome Database (HMDB) and 
data obtained from various research papers.22,23,24,25 All assigned values were then subjected 
to multivariate statistical analysis to identify the altered metabolic pattern.
Histological Staining
The animals were anaesthetized and transcardially perfused with phosphate buffer 
saline (PBS) (pH 7.4, 0.1 M) followed by fixation with 4% paraformaldehyde. Brain and liver 
samples were post-fixed in 4% formalin prepared in PBS for 24 hours. Fixed tissues were 
dehydrated in various grades of alcohol and cleared in benzene. Tissues were removed; 
transverse sections were embedded in molten paraffin wax and sections of 5 microns 
thickness were cut using a microtome. Brain sections were stained with hematoxylin and 
eosin (H & E) for detection of necrosis.26 The number of pyknotic cells/field was analyzed 
using ImageJ software (NIH, Bethesda, MD, USA). Liver samples were stained with Sirius 
Red (SR) and Masson Trichome (MT) to assess liver fibrosis. The percentage of SR and MT 
stained sections in the portal areas of liver tissue were measured using ImageJ software (NIH, 
Bethesda, MD, USA).
Neurobehavioral studies
Each animal was subjected to a set of neurobehavioral tests for learning, memory, 
anxiety and depression. 
Morris water maze test: Spatial learning and memory of the animals were assessed by Morris 
water maze test.27 The maze consisted of a circular water tank (140 cm in diameter and 60 cm 
in height) with water maintained at 25± 2°C and at a level of 40 cm above the floor of tank. A 
plexiglass platform invisible to the rats was placed 2 cm below the water level inside the 
tank. During the training session, each rat was placed at starting point of all four quadrants 
randomly. During the test, rat placed at starting point of one of the four quadrants had to 
escape to the platform submerged underneath the water. The rat was allowed to remain on the 
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platform for 20 seconds before the commencement of the next trial. The rat was guided to the 
platform if it could not reach the platform within the maximum allowed time of 180 seconds. 
The time taken (escape latency) and distance travelled to reach the platform was recorded at 
day 0 (before BDL), 14, and 21 post BDL surgery using ANY-maze TMvideo tracking 
software (Stoelting, Wood Dale, IL, USA).
A probe trial was performed on  day 22 of the BDL surgery, wherein the extent of 
memory retrieval was assessed as described by Vorhees and Williams. In the probe trial test 
hidden plexiglass platform was removed from the pool and rats were allowed to explore the 
maze for 180 seconds. Various parameters including time spent, number of entries and 
distance travelled in the quadrant containing platform were recorded. 
Open field test: The open field test provides simultaneous measures of locomotion, 
exploration and anxiety.28 The open field apparatus consisted of black plywood chamber (72 
cm x 72 cm with 36 cm walls). Each animal was allowed to spend 5 minutes in the apparatus 
and the parameters such as total distance travelled and total time (mobile) were used for the 
measurement of locomotion. The number of central square entries and rearing frequency 
were used as measures of anxiety.
Sucrose Preference test: Depression-like-symptoms viz. anhedonia (inability to feel pleasure 
in normal pleasurable activities) were evaluated using sucrose preference test (SPT). The 
rodents have an inherent interest for sweet foods or solutions.29 Reduced preference for sweet 
represents anhedonia. SPT was performed in the home cage. The rats were presented with 
two bottles one contained normal drinking water and second contained 2% (w/v) sucrose 
solution. The water and sucrose intake was measured daily for 3 days and the position of two 
bottles were reversed to reduce any side bias. Prior to begin the test, the rats were habituated 
to two drinking bottles for at least 3 days. After habituation, the rats were separated with 
single animal per cage and presented with two drinking bottles. Sucrose preference was 
calculated as a percentage of the volume of sucrose intake over the total volume of water 
intake and averaged over the 3 days of testing.30
𝑆𝑢𝑐𝑟𝑜𝑠𝑒 𝑃𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 =
𝑉𝑜𝑙𝑢𝑚𝑒 (𝑆𝑢𝑐𝑟𝑜𝑠𝑒 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛)
𝑉𝑜𝑙𝑢𝑚𝑒 (𝑆𝑢𝑐𝑟𝑜𝑠𝑒 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛) +  𝑉𝑜𝑙𝑢𝑚𝑒 (𝑊𝑎𝑡𝑒𝑟) × 100
Statistical Analysis
The data is expressed as mean ± standard error mean (SEM) and analyzed using 
independent t-test between the groups to analyse behavioural and histological parameters. 
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Values with p < 0.05 were considered as statistically significant. The 1H NMR spectral data 
were converted to comma-separated values (CSV) format using Microsoft excel and imported 
into MetaboAnalyst3.0 for multivariate analysis. Initially, principal component analysis 
(PCA) was applied to identify the clustering patterns and outliers. Partial least squares 
discrimination analysis (PLS-DA) was used for pattern recognition analysis and isolating 
significant metabolites based on their PLS-DA, variable influence on projection (VIP) and 
coefficient scores. PLS-DA model was validated by 10-fold cross validation method by 
describing R2 and Q2 values. R2 indicates goodness of fit and the predictive capability while 
Q2> 0.5 indicate that the models possessed a satisfactory fit with good predictive power. 
Two-tailed Pearson’s correlation and regression analyses were performed to find the relation 




Table 1 depicts the activity of ALP and levels of bilirubin, and cholesterol. The serum 
levels of total, direct (conjugated), and indirect (unconjugated) bilirubin showed 21-, 25- and 
19-fold increase in BDL rats. The activity of ALP enzyme in serum was significantly 
increased in BDL rats by 2-fold. An increase by 2-fold was also observed in cholesterol level 
in the case of BDL rats compared to the sham controls. Thus, these results reflect the 
impairment in liver functions induced by the BDL. 
Metabolic profiling 
Metabolic alterations in liver:
A typical 1D 1H NMR spectra of the aqueous phase from liver of  SC and BDL 
animals is shown in Figure 1. The NMR spectra reveal signals mainly from amino acids (e.g. 
leucine, isoleucine, valine, arginine, lysine, proline, glutamate, methionine, glycine, tyrosine 
and phenylalanine). Other identified metabolites were lactate, acetate, succinate, creatine, 
choline, betaine, glucose, taurine and pyridoxine. All these metabolites are shown in Table 2 
with their chemical shift values and VIP scores. Out of many altered metabolites, the mean 
concentration of glucose, phenylalanine and pyridoxine were significantly decreased, while 
BCAAs (isoleucine, leucine, and valine), lactate, arginine, glutamate, succinate, methionine, 
creatine, tyrosine, antioxidants and/or osmolytes (betaine, choline, taurine and glycine) were 
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significantly increased. These differentially expressed metabolites were mapped to amino 
acid metabolism, Krebs cycle and glycolysis pathway as depicted in Figure 3A. 
Metabolic alterations in brain:
Figure 1 illustrates 1H NMR spectrum of the aqueous phase from the cortex of SC 
and BDL animals. In cortex, the mean concentration of propylene glycol, methylmalonate, 
creatine, choline, taurine, glucose and myo-inositol were significantly decreased, while 
neurotransmitters (N-acetylglutamate/N-acetylaspartate (NAA/NAG), glutamate, 4-
aminobutyrate, and glutamine), TCA cycle intermediates (succinate, citrate and malate), 
acetate, glycine and lactate were significantly increased in BDL animals. All these 
metabolites were shown in Table 3 with their chemical shift values and VIP scores.
1H NMR spectra of hippocampus obtained from SC and BDL animals are shown in 
Figure 1.  In hippocampus, the mean concentration of amino acids (isoleucine, alanine, 
proline and leucine), propylene glycol, malate (TCA cycle intermediate), creatine, 
antioxidants and/or osmolytes (choline, betaine and taurine), glucose and myo-inositol were 
significantly decreased, while methylmalonate, acetate, neurotransmitters (NAA/NAG, 
glutamate, 4-aminobutyrate, glutamine), TCA cycle intermediates (succinate and citrate), 
amino acids (aspartate, glycine and tyrosine), methanol and lactate were significantly 
increased in BDL animals as compared to SC. All these metabolites were shown in Table 4 
with their chemical shift values and VIP scores. Thus, the metabolites responsible for 
separating BDL group from control included alterations in neurotransmission and energy 
metabolic pathways in Figure 3B.  
Multivariate analysis
The unsupervised PCA of the metabolite data from all samples revealed the general 
structure of the complete data set. In PCA plots, the samples with similar metabolic profile 
grouped together while the samples with altered metabolism were found to be dispersed 
(Figure 2). The HE group showed considerable difference from the control group by 
increased PC2 scores and decreased PC1 scores in liver. In cortex, control and HE groups 
reflected similar metabolic profiles while, in hippocampus, HE group showed considerable 
difference from the control group by increased PC2 scores. Thus, as a result, PC2 appears to 
be responsible for the separation between control and HE groups in liver and hippocampus. 
PLS-DA was applied to obtain an overview of the complete data set and discriminate the 
variables that are responsible for variation between the groups to identify features with 
Page 9 of 37
ACS Paragon Plus Environment






























































discriminative power. The quality and reliability of the PLS-A models were validated based 
on R2 and Q2 values derived using 10-fold cross validation algorithm. The R2 and Q2 values 
in the Figure 2 alluded that the PLS-DA models possessed satisfactory fit with good 
predictive power. These results indicate that the established PLS-DA model is reliable and 
good in classifying and discriminating between SC and the BDL group. The differential 
metabolites were selected based on the statistically significant threshold of VIP values (i.e., 
≥1.0) obtained from the PLS-DA model and PLS-DA coefficients score (i.e., >30% in the 
present study). The coefficient importance is based on the weighted sum of PLS regression 
scores; whereas the VIP score represents a weighted sum of squares of the PLS loadings and 
takes into account the amount of explained Y variation in each dimension to measure the 
impact of each metabolite in the model. The VIP criterion indirectly imitates the correlation 
of the metabolites with disease and is an extensively used method for biomarker selection. In 
addition, the permutation test plots showed that the Q2 regression line had a negative 
intercept and all of the permutated R2 and Q2 values to the left were lower than the original 
points to the right (Figure 2), which indicated that the models in the present study are valid.
Histopathological changes in liver
Sirius red staining revealed a significant increase in the collagen content, typical 
perisinusoidal, periportal, and peribiliary fibrosis, resulting in the formation of fibrotic septae 
and deposition of extra cellular matrix in BDL rats three weeks after the surgery (Figure 4). 
Moreover, percentage of Sirius red stained area was significantly higher in the BDL rats as 
compared to SC rats (Figure 4C). Furthermore, Masson trichome stain also revealed severe 
liver injury that included cellular destruction, infiltration of lymphocytes and visible collagen 
accumulation in the BDL animals as compared to sham controls (Figure 4E). The Masson 
trichrome stained area (blue) was significantly higher in BDL rats as compared to SC rats 
(Figure 4F). Liver of sham controls showed a normal morphology with intact hepatocytes 
and portal tracts (Figure 4A&D). Liver of BDL rats showed biliary fibrosis accompanied by 
loss of hepatic structure (Figure 4B&E). 
Histopathological changes in Brain
In brain, H & E staining of cortex and hippocampus sections of BDL rats showed 
marked increase in neuronal degeneration, pyknotic and shrunken neurons as compared to SC 
rats (Figure 4G, H, I &J) 
Neurobehaviour tests
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A significant increase was observed in the distance travelled (5.1 fold) and total time 
taken (11.6 fold) by the BDL rats to reach the quadrant containing the platform (Descent 
latency) as compared to the SC rats on day 21  post BDL (Figure 5B & C). This was also 
evident from the track plot reports wherein the track lines reflect the path followed by the 
animal to locate the hidden platform (Figure 5A). In the memory retrieval test performed on 
day 22, a significant decline was observed in the number of entries (42%), time spent (48%) 
and distance travelled (37%) by the BDL rats in the quadrant containing platform as 
compared to SC rats (Table 5). This suggested impaired learning and memory in BDL rats. 
Further, Table 6.1 and 6.2 summarizes Pearson correlation between metabolic profile of 
cortex and hippocampus with the behavioural parameters. Interestingly, we observed a 
significant correlation between descent latency and NAA/choline (Cortex: r= 0.68, p<0.05; 
Hippocampus: r= 0.69, p<0.05, Figure 8A), descent latency and choline/creatine (Cortex: r= 
- 0.65, p<0.05; Hippocampus: r= - 0.67, p<0.05, Figure 8B), descent latency and 
NAA/creatine (Cortex: r=  0.75, p<0.05; Hippocampus: r =  0.70, p<0.05, Figure 8C).
Open field test: 
Locomotion and anxiety like behaviour evaluated using open field test showed 
significant decline in total distance travelled (3.5 fold) and mobility time (3.3 fold) by the 
animals that underwent BDL surgery as compared to SC (Figure 6B & C). However, a 
significant decrease was also observed in the frequency of entries to the central zone (5.1 
fold) and frequency of rearing (4.2 fold) on day 21 post surgery as compared to SC (Figure 
6D & E). This was also evident from the track plot that reflects the path followed by the 
animal during exploration (Figure 6A). Thus, the BDL animals showed reduced locomotion 
and increased anxiety like behaviour. Further, there was a significant correlation between 
total distance travelled and NAA/choline (Cortex: r = - 0.67, p<0.05; Hippocampus: r = -
0.64, p<0.05, Figure 9A), total distance travelled and choline/creatine (Cortex: r =  0.62, 
p<0.05; Hippocampus: r = 0.64, p<0.05, Figure 9B), total distance travelled and 
NAA/creatine (Cortex: r = - 0.67, p<0.05; Hippocampus: r = - 0.64, p<0.05, Figure 9C). 
Moreover, Table 6.1 and 6.2 summarizes the pearson correlation of all the metabolites with 
the time animal was mobile and total distance travelled. 
Sucrose preference test:
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Depression like behaviour was assessed in terms of intake of sucrose over water 
which was measured for 3 days post surgery. Figure 7 depicts that BDL rats exhibited a 78 % 
decrease in sucrose preference as compared to SC. BDL rats exhibited decreased ability to 
experience pleasure and thus showing depressive like behaviour. Further, the depressive-like 
behaviour was correlated with the metabolic profiles of cortex and hippocampus (Table 6.1 
and 6.2). 
Discussion 
Hepatic encephalopathy is a well known complication of liver cirrhosis. The animal 
model that is particularly useful for the study of HE is the bile duct ligation (BDL) model. 
Various studies have reported increase in the ammonia levels following BDL. This model is 
also associated with elevated liver enzymes, increase in hepatic collagen and hydroxyproline 
content leading to the development of liver fibrosis in rats.31 Similarly, in the present study, 
increased activity of ALP, bilirubin and cholesterol were observed in BDL animals as 
compared to control. The histological staining of liver showed deposition of collagen and loss 
of hepatic structure in BDL animals. Since, HE is an inter-organ disease that triggers a 
pathophysiological cascade of events affecting other organs that results in changes at the 
metabolic level. These changes often show their manifestations in term of presence, absence 
or altered concentration of the affected metabolite(s), in the bio fluids and tissues. Here, the 
present study reveals metabolic perturbations in response to HE using 1H NMR based 
metabolomics. 
Analysis of 1H NMR metabolic profiles of both liver and brain from sham control 
versus BDL group revealed clear differences that were rapidly characterized using 
multivariate statistical approaches. The major metabolic disturbance detected in the liver of 
BDL rats includes increased levels of lactate and decreased levels of glucose. Decreased 
glucose levels reflect either impairment in glucose uptake or increased rate of glucose 
metabolisation. Increase in the rate of glycolysis is a well-known phenomenon in acute and 
chronic HE and hyperammonemia.32 Increased lactate levels in liver suggest that pyruvate 
generated in glycolysis was converted to lactate, instead of being channelled to TCA cycle. 
Similarly, in low or chronic alcohol consumption, excess lactic acid is transported from the 
liver to peripheral tissues, where energy level is lower, and lactic acid may be reconverted to 
pyruvic acid for metabolic needs. Moreover, it is reported that in acute alcohol consumption, 
TCA cycle is known to be inhibited33, which was also indicated in our study by the increased 
levels of TCA cycle intermediate such as succinate and glutamate. Glutamate, the precursor 
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of glutamine is the most abundant amino acids involved in nitrogen metabolism. Glutamine 
enters into the TCA cycle following its deamination into ketoglutarate. In other liver 
pathologies such as hepatocellular carcinoma, hepatic transplantation failure and fulminant 
hepatitis, the levels of glutamine were found to be increased in plasma, serum as well as in 
urine.34,35,36  
The amino acids are also detectable in liver that mainly includes BCAAs such as 
valine, leucine and isoleucine, which serve as a substrate for protein synthesis, 
glyconeogenesis and act as a precursor for various hormones. The increased levels of free 
BCAAs in the liver of BDL rats reflected increased degradation of proteins and the higher 
release of these amino acids by the liver. Muscles along with liver release a high quantity of 
amino acids present in the body to maintain cellular homeostasis in condition of energy 
deprivation.37 Additionally, increased levels of arginine were observed in liver of BDL group. 
This increase in arginine causes the increase in proline production and proline is responsible 
for the deposition of collagen in the liver.38 Increased collagen content in liver has also been 
shown by histopathological staining with sirius red and masson trichome Increased collagen 
correlated with the increase in the free proline was also evident in experimental fibrosis39  
and human cirrhosis.40
 In brain, increased lactate and decreased glucose levels in BDL animals indicates 
impaired aerobic glycolysis and TCA cycle and thus dampened the ATP production. These 
results are consistent with the previous reports in patients with HE and hyperammonemia as 
well as in animals with acute liver failure.41,42,43,44 Amino acids serve as a key source of 
energy, especially during conditions in which glucose availability is limited. The levels of 
BCAAs including isoleucine and leucine were found to be low in the brain of BDL rats. 
Isoleucine and leucine are ketogenic amino acids and as the levels of acetate were increased 
so it might be an index of ketogenesis in encephalopathy. Moreover, the major change found 
in brain involves alterations in neurotransmitter levels. Glutamate is the main excitatory 
neurotransmitter of the central nervous system. The levels of glutamate, glutamine and 4-
aminobutyrate (GABA) were increased in BDL rats as compared to control. Montana et al. 
also observed increased glutamate release from astrocytes in HE.45 The glutamine/glutamate 
(Gln/Glu)- GABA cycle (GGC) between astrocytes and neurons has been known to be the 
brain’s primary mechanism for ammonia detoxification. Disturbance in GGC in brain results 
in hyperammonemia which leads to cognitive and motor impairments. These findings were 
further supported by the neurobehavioral tests which revealed significant impairment in 
cognition and motor functions. Memory and learning impairment during HE was assessed by 
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morris water maze test, which showed a progressive increase in the transfer latency and the 
distance travelled to reach the hidden platform from day 14 onwards to day 21 suggesting 
impaired memory acquisition. Similarly, Huang et al. have shown that swim length used as a 
measure of spatial memory, was higher in case of BDL rats as compared to SC rats.46 
Memory and learning impairment during HE can also be linked with the decreased levels of 
choline in brain as cholinergic system has been shown to be associated with memory.47 
Choline is responsible for the formation of important neurotransmitter: acetylcholine and two 
major phospholipids: phosphatidylcholine and sphingomyelin. Studies have shown that 
decreased levels of choline and acetylcholine in the hippocampus and adjacent cortical areas 
produces memory loss comparable to anterograde amnesia.48 Choline and myo-inositol are 
considered important osmolytes in astrocytes.49 In the present study, decreased levels of both 
were found in the brain which reflects increased cell swelling that may leads to brain edema. 
Brain edema is one of the pathological conditions in HE patients.50 A decreased levels are 
also observed in acute liver failure and HE patients51 which is similar to what is seen in our 
results. Furthermore, we have also found a significant correlation between NAA/Choline and 
Choline/Creatine ratio with the descent latency and total distance travelled, indicating a 
specific metabolic link with cognitive and motor impairments following BDL. Similarly, Ben 
Salem et al also reported NAA/Creatine and Choline/Creatine ratios as a marker of cognitive 
impairment in the elderly population.52
The alterations in neurotransmitter levels in brain reflect the behavioural impairemt in 
BDL rats. These behavioural changes are of interest as it is well known that patients with 
chronic HE exhibit impaired Cognitive and motor functions. Anxiety and depression are also 
the most common symptoms in HE.53  In the present study, BDL rats have shown a decrease 
in locomotor and exploratory activity while undergoing the open field behavioural task.. 
Depressive like behaviour was also shown by the BDL rats as assessed by sucrose preference 
test. Similarly, Jiang et al. showed that BDL surgery induced a significantly reduced sucrose 
preference in rats, while the indoleamine-2,3-dioxygenase (IDO) inhibitor 1-MT treatment 
reversed this decrease, indicating depression is accompanied by HE.54 
In conclusion, our results indicated significant dysregulation of metabolic pathways in 
both liver and brain. The metabolic alterations were associated with the disturbance of energy 
metabolism (glycolysis, TCA cycle and ketogenesis), amino acid metabolism and 
neurotransmission in brain. Additionally, BDL induced neurobehavioral abnormalities appear 
to result from altered energy metabolism and neurotransmitter levels, which were observed in 
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both cortex and hippocampus. Thus, the combination of these metabolic alterations may hold 
promise for early prediction and development of better prognostic markers.  
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Figure 1: Stack plot of representative 1D 1H NMR spectra from liver, Cortex and 
hippocampus of SC and BDL animals.
Figure 2: Two dimensional PCA and PLS-DA score plots derived from one dimensional 1H 
CPMG NMR spectra of liver (A, B) cortex (D, E) and hippocampus (G, H) from SC and 
BDL groups. Each data point denotes one subject. A 100 random permutation test for PLS-
DA models generated from liver (C), cortex (F) and hippocampus (I) of control and BDL 
groups. The R2 value (green) represents the goodness of fit of the model. The Q2 value (blue) 
represents the predictability of the models.  
Figure 3: Metabolic pathways related to metabolites altered in the liver (A) and brain (B) of 
BDL animals. 
 
Figure 4: Photomicrographs of liver and brain sections from SC (A,D,G,I) and BDL rats 
(B,E,H,J) at magnification, 600X. Liver sections stained with Sirius red are shown in A and B 
whereas with masson trichome are reported in D and E.  Arrows indicate collagen stained 
areas and percentage of Sirius red and masson trichome stained area analyzed using ImageJ 
(C and F, respectively). Cortex (G and H) and hippocampus (I and J) sections were stained 
with H&E. Arrows indicate pyknotic neuronal cells. Number of pyknotic cells/field analyzed 
using ImageJ (K).  Values are expressed as mean ± SEM; n=3. *Significantly different from 
control group (P<0.05).
Figure 5: Effect of BDL on learning and memory assessed by Morris water maze test. 
Representative track plots of animals recorded using video tracking software ANY-maze (A) 
distance travelled (B) and total time (C). Values are expressed as mean ± SEM; 
n = 5. *Significantly different from SC group (p < 0.05).
Figure 6: Effect of BDL on locomotor functions assessed by open field test. Representative 
track plots of animals recorded using video tracking software ANY-maze (A), total distance 
travelled (B) time mobile (C) No. of center zone entries (D) and Rearing frequency (E). 
Values are expressed as mean ± SEM; n = 5. *Significantly different from SC group 
(p < 0.05).
Figure 7: Effect of BDL on depressive behavior assessed by sucrose water preference test. 
Values are expressed as mean ± SEM; n=5. *Significantly different from SC group 
(P<0.005).
Figure 8: Correlation plots showing the relation between cognitive behaviour with the 
metabolic profiles from SC and BDL. Correlation between descent latency and NAA/Choline 
(A), Choline/Creatine (B) and NAA/Creatine (C). Two-tailed Pearson correlation were 
performed. 
Figure 9: Correlation plots showing the relation between Motor behavior with the metabolic 
profiles from SC and BDL. Correlation between total distance travelled and NAA/Choline 
(A), Choline/Creatine (B) and NAA/Creatine (C). Two-tailed Pearson correlation were 
performed.
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Table 1: Effect of BDL on liver function tests.
                                                                          SC                                      BDL
Total bilirubin (mg/dl)          0.31±0.03                 6.63±1.23*
Direct bilirubin (mg/dl)                           0.13±0.02                         3.27±0.86*
Indirect bilirubin (mg/dl)                        0.17±0.04                         3.36±1.12*
ALP (IU/L)                                             274.4±28.8                       532.6±29.7*
Cholesterol (mg/dl)                                 51.05±3.5                         115.03±7.7*
Values are expressed as mean ±SD; n=5.*significantly different from control group (P < 0.05)
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Table 2: Significant change in the metabolites derived from liver of SC and BDL animals.
Metabolite ppm VIP Score Level
Isoleucine 0.93 1.0 Increase
Leucine 0.95 1.5 Increase
Valine 1.03 1.5 Increase
Lactate 1.31 4.1 Increase
Arginine 1.73 1.3 Increase
Acetate 1.91 0.5 Increase
Proline 1.99 0.6 Increase
Glutamate 2.05 1.6 Increase
Succinate 2.39 1.1 Increase
Methionine 2.63 0.9 Increase
Creatine 3.03 1.8 Increase
Tyrosine 3.07 1.8 Increase
Choline 3.19 2.8 Increase
Betaine 3.25 2.3 Increase
Glucose 3.39 3.4 Decrease
Taurine 3.43 1.9 Increase
Glycine 3.55 1.6 Increase
Lactate 4.09 1.7 Increase
Phenylalanine 7.47 1.0 Decrease
Pyridoxine 7.67 1.1 Decrease
Page 22 of 37
ACS Paragon Plus Environment






























































Table 3: Significantly altered metabolites from cortex of SC and BDL animals.
       Metabolite                            ppm VIP Score          Level
Propylene Glycol 1.13 1.3 Decrease
3-Hydroxyisovalerate 1.23 1.7 Increase
Methylmalonate 1.25 1.3 Decrease
Acetate 1.89 1.6 Increase
NAA/NAAG 2.01 2.1 Increase
Glutamate 2.13 4.7 Increase
4-Aminobutyrate 2.29 1.5 Increase
Succinate 2.39 2.3 Increase
Glutamine 2.45 4.1 Increase
Citrate 2.51 1.2 Increase
Malate 2.69 1.0 Increase
Creatine 3.03 1.8 Decrease
Choline 3.19 1.9 Decrease
Taurine 3.41 1.3 Decrease
Glucose 3.53 2.2 Decrease
Glycine 3.55 1.7 Increase
Myo-Inositol 3.61 1.8 Decrease
Lactate 4.09 1.0 Increase
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Table 4:  Significantly altered metabolites from Hippocampus of SC and BDL animals.
Metabolite ppm VIP Score Level
Isoleucine 0.93        1.0 Decrease
Leucine 0.95 1.1 Decrease
Propylene Glycol 1.13 1.3 Decrease
3-Hydroxyisovalerate 1.23 2.1 Increase
Methylmalonate 1.25 2.4 Increase
Alanine 1.45 1.0 Decrease
Acetate 1.89 1.8 Increase
Proline 1.99 1.5 Decrease
NAA/NAAG 2.01 1.1 Increase
Glutamate 2.03 1.3 Increase
4-Aminobutyrate 2.29 1.7 Increase
Succinate 2.39 3.3 Increase
Glutamine 2.45 4.0 Increase
Citrate 2.51 1.7 Increase
Malate 2.69 1.1 Decrease
Aspartate 2.79 1.2 Increase
Creatine 3.03 1.4 Decrease
Choline 3.19 2.7 Decrease
Glucose 3.23 1.5 Decrease
Betaine 3.25 1.8 Decrease
Methanol 3.35 2.4 Increase
Taurine 3.41 1.4 Decrease
Glycine 3.55 2.5 Increase
Myo-Inositol 3.61 2.7 Decrease
Lactate 4.07 1.6 Increase
Tyrosine 6.89 1.0 Increase
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Table 5: Probe trial activity assessed by Morris water maze in SC and BDL animals.
       SC                          BDL
Number of Entries in the Quadrant 23.33 ± 2.02 13.67 ± 2.34*
Containing Platform
Time Spent in the Quadrant containing    88.66 ± 4.63 45.94 ± 5.20*
Platform (Seconds)
Distance Travelled in the Quadrant  39.67 ± 2.42 25.09 ± 1.50*
Containing platform (m)
Values are expressed as mean ±SD; n=5.*significantly different from control group (P < 0.05)
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Table 6.1:  Tabulated summary of Pearson correlation coefficients (r) between metabolic profile of cortex 
and the behavioural parameters. 
Descent Latency Time mobile Total distance travelled Sucrose preference
Behavioural Parameters
Metabolites







































































  0.71*   0.47
  0.24   0.32
  0.54   0.65*
- 0.76** - 0.59
- 0.34 - 0.49
- 0.45 - 0.33
- 0.69* - 0.51
- 0.81** - 0.77**
- 0.81** - 0.95***
- 0.51 - 0.70*
- 0.45 - 0.57
  0.52   0.43
  0.67*   0.77**
  0.35   0.19
  0.77**   0.79**
- 0.61 - 0.56
  0.68*   0.72*
- 0.31 - 0.43
*p<0.05, **p<0.01, ***p<0.001
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Table 6.2:  Tabulated summary of Pearson correlation coefficients (r) between metabolic profile of 
Hippocampus and the behavioural parameters. 














































































  0.18   0.41
  0.78   0.64*
- 0.42 - 0.45
- 0.38 - 0.49
  0.40
0.81**





- 0.72* - 0.75
  0.26   0.41
- 0.49 - 0.32


































   0.40
   0.53
   0.60
- 0.77**
  0.51
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Figure 1: Stack plot of representative 1D 1H NMR spectra from liver, Cortex and hippocampus of SC and 
BDL animals. 
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Figure 2: Two dimensional PCA and PLS-DA score plots derived from one dimensional 1H CPMG NMR spectra 
of liver (A, B) cortex (D, E) and hippocampus (G, H) from SC and BDL groups. Each data point denotes one 
subject. A 100 random permutation test for PLS-DA models generated from liver (C), cortex (F) and 
hippocampus (I) of control and BDL groups. The R2 value (green) represents the goodness of fit of the 
model. The Q2 value (blue) represents the predictability of the models.   
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Figure 3: Metabolic pathways related to metabolites altered in the liver (A) and brain (B) of BDL animals. 
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Figure 4: Photomicrographs of liver and brain sections from SC (A,D,G,I) and BDL rats (B,E,H,J) at 
magnification, 600X. Liver sections stained with Sirius red are shown in A and B whereas with masson 
trichome are reported in D and E.  Arrows indicate collagen stained areas and percentage of Sirius red and 
masson trichome stained area analyzed using ImageJ (C and F, respectively). Cortex (G and H) and 
hippocampus (I and J) sections were stained with H&E. Arrows indicate pyknotic neuronal cells. Number of 
pyknotic cells/field analyzed using ImageJ (K).  Values are expressed as mean ± SEM; n=3. *Significantly 
different from control group (P<0.05). 
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Figure 5: Effect of BDL on learning and memory assessed by Morris water maze test. Representative track 
plots of animals recorded using video tracking software ANY-maze (A) distance travelled (B) and total time 
(C). Values are expressed as mean ± SEM; n = 5. *Significantly different from SC group (p < 0.05). 
119x125mm (300 x 300 DPI) 
Page 33 of 37
ACS Paragon Plus Environment






























































Figure 6: Effect of BDL on locomotor functions assessed by open field test. Representative track plots of 
animals recorded using video tracking software ANY-maze (A), total distance travelled (B) time mobile (C) 
No. of center zone entries (D) and Rearing frequency (E). Values are expressed as mean ± SEM; n = 5. 
*Significantly different from SC group (p < 0.05). 
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Figure 7: Effect of BDL on depressive behavior assessed by sucrose water preference test. Values are 
expressed as mean ± SEM; n=5. *Significantly different from SC group (P<0.005). 
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Figure 8: Correlation plots showing the relation between cognitive behaviour with the metabolic profiles from 
SC and BDL. Correlation between descent latency and NAA/Choline (A), Choline/Creatine (B) and 
NAA/Creatine (C). Two-tailed Pearson correlation were performed. 
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Figure 9: Correlation plots showing the relation between Motor behavior with the metabolic profiles from SC 
and BDL. Correlation between total distance travelled and NAA/Choline (A), Choline/Creatine (B) and 
NAA/Creatine (C). Two-tailed Pearson correlation were performed. 
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